176 related articles for article (PubMed ID: 19365629)
21. The EFEMEREYE Study: prenatal medication exposure and ocular anomaly occurrence in EFEMERIS health database.
Dubucs C; N'Go V; Caillet A; Cifuentes EA; Beau AB; Frémont F; Hurault-Delarue C; Courtade-Saïdi M; Damase-Michel C
J AAPOS; 2024 Jun; 28(3):103931. PubMed ID: 38719141
[TBL] [Abstract][Full Text] [Related]
22. First trimester pregnancy exposure to fosfomycin and risk of major congenital anomaly: a comparative study in the EFEMERIS database.
Benevent J; Araujo M; Beau AB; Sicard D; Sommet A; Hurault-Delarue C; Lacroix I; Damase-Michel C
Infection; 2023 Feb; 51(1):137-146. PubMed ID: 35689790
[TBL] [Abstract][Full Text] [Related]
23. The French Pregnancy Cohort: Medication use during pregnancy in the French population.
Bérard A; Abbas-Chorfa F; Kassai B; Vial T; Nguyen KA; Sheehy O; Schott AM
PLoS One; 2019; 14(7):e0219095. PubMed ID: 31314794
[TBL] [Abstract][Full Text] [Related]
24. What changes in prescription patterns of antiemetic medications in pregnant women in France?
Hurault-Delarue C; Araujo M; Vabre C; Benevent J; Damase-Michel C; Lacroix I
Fundam Clin Pharmacol; 2021 Dec; 35(6):1159-1167. PubMed ID: 33866614
[TBL] [Abstract][Full Text] [Related]
25. Atropinic burden of drugs during pregnancy and psychological development of children: a cohort study in the EFEMERIS database.
Beau AB; Montastruc JL; Lacroix I; Montastruc F; Hurault-Delarue C; Damase-Michel C
Br J Clin Pharmacol; 2016 Aug; 82(2):478-86. PubMed ID: 27085086
[TBL] [Abstract][Full Text] [Related]
26. Prescription drugs among pregnant women in Lome, Togo, West Africa.
Potchoo Y; Redah D; Gneni MA; Guissou IP
Eur J Clin Pharmacol; 2009 Aug; 65(8):831-8. PubMed ID: 19337728
[TBL] [Abstract][Full Text] [Related]
27. POMME: The New Cohort to Evaluate Long-Term Effects After Prenatal Medicine Exposure.
Benevent J; Hurault-Delarue C; Araujo M; Montastruc JL; Lacroix I; Damase-Michel C
Drug Saf; 2019 Jan; 42(1):45-54. PubMed ID: 30121741
[TBL] [Abstract][Full Text] [Related]
28. Pregnancy outcomes in women exposed to cancer chemotherapy.
Danet C; Araujo M; Bos-Thompson MA; Portolan G; Gautier S; Vanlemmens L; Bonenfant S; Jonville-Béra AP; Cottin J; Vial T; Bavoux F; Montastruc JL; Damase-Michel C; Benevent J; Bourgeois-Mondon I; Lacroix I
Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1302-1308. PubMed ID: 30379378
[TBL] [Abstract][Full Text] [Related]
29. Prescription drug use during pregnancy in France: a study from the national health insurance permanent sample.
Demailly R; Escolano S; Quantin C; Tubert-Bitter P; Ahmed I
Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1126-1134. PubMed ID: 28758270
[TBL] [Abstract][Full Text] [Related]
30. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study.
Graner S; Svensson T; Beau AB; Damase-Michel C; Engeland A; Furu K; Hviid A; Håberg SE; Mølgaard-Nielsen D; Pasternak B; Kieler H
BMJ; 2017 Feb; 356():j629. PubMed ID: 28246106
[No Abstract] [Full Text] [Related]
31. Topical sertaconazole during pregnancy and risk of adverse pregnancy outcome and major congenital anomalies: Comparative study in the EFEMERIS database.
Araujo M; Hurault-Delarue C; Sommet A; Damase-Michel C; Lacroix I
Mycoses; 2022 Apr; 65(4):481-489. PubMed ID: 35067990
[TBL] [Abstract][Full Text] [Related]
32. Prescription drug use in pregnancy and variations according to prior psychiatric history.
Ingstrup KG; Liu X; Gasse C; Debost JP; Munk-Olsen T
Pharmacoepidemiol Drug Saf; 2018 Jan; 27(1):105-113. PubMed ID: 29171114
[TBL] [Abstract][Full Text] [Related]
33. Off-label prescribing during pregnancy in France: the NéHaVi cohort
.
Laroche ML; Blin A; Coubret A; Grau M; Roux B; Aubard Y
Int J Clin Pharmacol Ther; 2020 Apr; 58(4):198-208. PubMed ID: 31933473
[TBL] [Abstract][Full Text] [Related]
34. Dispensing of Potentially Harmful Prescription Drugs in 1.8 Million Pregnant Women in France: A Nationwide Study Based on Two Risk Classification Systems.
Blotière PO; Damase-Michel C; Weill A; Maura G
Drug Saf; 2021 Dec; 44(12):1323-1339. PubMed ID: 34613596
[TBL] [Abstract][Full Text] [Related]
35. Agreement between paternal self-reported medication use and records from a national prescription database.
Cohen JM; Wood ME; Hernandez-Diaz S; Nordeng H
Pharmacoepidemiol Drug Saf; 2018 Apr; 27(4):413-421. PubMed ID: 29488294
[TBL] [Abstract][Full Text] [Related]
36. Prescription of drugs during pregnancy in France.
Lacroix I; Damase-Michel C; Lapeyre-Mestre M; Montastruc JL
Lancet; 2000 Nov; 356(9243):1735-6. PubMed ID: 11095263
[TBL] [Abstract][Full Text] [Related]
37. Drug exposure during the periconceptional period: a study of 1793 women.
Autret-Leca E; Deligne J; Leve J; Caille A; Cissoko H; Jonville-Bera AP
Paediatr Drugs; 2011 Oct; 13(5):317-24. PubMed ID: 21888445
[TBL] [Abstract][Full Text] [Related]
38. Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006).
Daw JR; Mintzes B; Law MR; Hanley GE; Morgan SG
Clin Ther; 2012 Jan; 34(1):239-249.e2. PubMed ID: 22169049
[TBL] [Abstract][Full Text] [Related]
39. Surveillance of Medication Use During Pregnancy in the Mini-Sentinel Program.
Andrade SE; Toh S; Houstoun M; Mott K; Pitts M; Kieswetter C; Ceresa C; Haffenreffer K; Reichman ME
Matern Child Health J; 2016 Apr; 20(4):895-903. PubMed ID: 26645616
[TBL] [Abstract][Full Text] [Related]
40. Prescription drug use among pregnant women in opioid Maintenance Treatment.
Lund IO; Skurtveit S; Engeland A; Furu K; Ravndal E; Handal M
Addiction; 2013 Feb; 108(2):367-76. PubMed ID: 22882166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
